[Altered hip muscle activation in patients with chronic non-specific low back pain].

PubWeight™: 0.81‹?›

🔗 View Article (PMID 21424336)

Published in Schmerz on April 01, 2011

Authors

D Nötzel1, C Puta, H Wagner, C Anders, A Petrovich, H H W Gabriel

Author Affiliations

1: Institut für Sportwissenschaft, Lehrstuhl für Sportmedizin, Friedrich-Schiller-Universität Jena. dirk.noetzel@uni-jena.de

Articles cited by this

Graphic representation of pain. Pain (1976) 14.25

Sensorimotor integration in human postural control. J Neurophysiol (2002) 5.88

Central programming of postural movements: adaptation to altered support-surface configurations. J Neurophysiol (1986) 5.61

Inefficient muscular stabilization of the lumbar spine associated with low back pain. A motor control evaluation of transversus abdominis. Spine (Phila Pa 1976) (1996) 4.82

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest (1983) 4.70

Unified theory regarding A/P and M/L balance in quiet stance. J Neurophysiol (1996) 3.61

Muscle response pattern to sudden trunk loading in healthy individuals and in patients with chronic low back pain. Spine (Phila Pa 1976) (2000) 2.08

Postural control system. Curr Opin Neurobiol (1994) 1.92

Fixed patterns of rapid postural responses among leg muscles during stance. Exp Brain Res (1977) 1.75

EMG responses to maintain stance during multidirectional surface translations. J Neurophysiol (1998) 1.67

Balance in chronic low back pain patients compared to healthy people under various conditions in upright standing. Clin Biomech (Bristol, Avon) (1999) 1.67

A unified view of quiet and perturbed stance: simultaneous co-existing excitable modes. Neurosci Lett (2004) 1.66

Muscle fibre orientation of abdominal muscles and suggested surface EMG electrode positions. Electromyogr Clin Neurophysiol (1998) 1.56

Body sway and vision. J Exp Psychol (1946) 1.43

The role of motor action in anticipatory postural adjustments studied with self-induced and externally triggered perturbations. Exp Brain Res (1995) 1.41

Muscular response to sudden load. A tool to evaluate fatigue and rehabilitation. Spine (Phila Pa 1976) (1996) 1.38

Visual and vestibular contributions to pitch sway stabilization in the ankle muscles of normals and patients with bilateral peripheral vestibular deficits. Exp Brain Res (1985) 1.33

A study of various normalization procedures for within day electromyographic data. J Electromyogr Kinesiol (1994) 1.27

Verbal encouragement: effects on maximum effort voluntary muscle action. Br J Sports Med (1996) 1.25

Muscle activation patterns in subjects with and without low back pain. Arch Phys Med Rehabil (2002) 1.23

European Spine Society--the AcroMed Prize for Spinal Research 1995. Unexpected load and asymmetric posture as etiologic factors in low back pain. Eur Spine J (1996) 1.20

Gluteus medius muscle activation patterns as a predictor of low back pain during standing. Clin Biomech (Bristol, Avon) (2008) 1.05

Influence of the subcutaneous fat layer, as measured by ultrasound, skinfold calipers and BMI, on the EMG amplitude. Eur J Appl Physiol (2003) 0.99

A non-MVC EMG normalization technique for the trunk musculature: Part 1. Method development. J Electromyogr Kinesiol (2001) 0.92

Low back pain suppresses preparatory and triggered upper-limb activation after sudden upper-limb loading. Spine (Phila Pa 1976) (2007) 0.92

Paraspinal muscle responses during sudden upper limb loading. Eur J Appl Physiol (2002) 0.88

A non-MVC EMG normalization technique for the trunk musculature: Part 2. Validation and use to predict spinal loads. J Electromyogr Kinesiol (2001) 0.87

The clinical significance of electromyography normalisation techniques in subjects with anterior cruciate ligament injury during treadmill walking. Gait Posture (2003) 0.85

Trunk loading and expectation. Ergonomics (1987) 0.81

Clinical considerations in the use of surface electromyography: three experimental studies. J Manipulative Physiol Ther (2002) 0.80

Influence of visual and somatosensory input on leg EMG responses in dynamic posturography in normals. Electroencephalogr Clin Neurophysiol (1994) 0.78

Manual therapy and exercise therapy in patients with chronic low back pain: a randomized, controlled trial with 1-year follow-up. Spine (Phila Pa 1976) (2004) 0.75

[Chronic low back pain--need for an interdisciplinary approach]. Anasthesiol Intensivmed Notfallmed Schmerzther (2008) 0.75

Articles by these authors

(truncated to the top 100)

A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med (1999) 5.84

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A (2001) 5.02

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med (1999) 4.81

A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med (2000) 4.54

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol (1981) 4.31

T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med (1992) 4.31

Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol (2001) 4.13

A neuronal learning rule for sub-millisecond temporal coding. Nature (1996) 3.76

T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity. J Exp Med (1978) 3.69

Retrovirus genomes methylated by mammalian but not bacterial methylase are non-infectious. Nature (1983) 3.43

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. J Exp Med (1977) 3.38

Synergy during in vitro cytotoxic allograft responses. I. Evidence for cell interaction between thymocytes and peripheral T cells. J Exp Med (1973) 3.24

Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J Sleep Res (2000) 3.17

Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem (2001) 3.16

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol (1998) 3.11

CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J (1998) 3.06

Virus and trinitrophenol hapten-specific T-cell-mediated cytotoxicity against H-2 incompatible target cells. J Exp Med (1976) 3.00

Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Invest Ophthalmol Vis Sci (1998) 2.68

Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology (2000) 2.46

T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice. Nature (1980) 2.39

CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol (1998) 2.31

[Surgical leg prolongation]. Chirurg (1971) 2.28

Primary responses of human T cells to mycobacteria: a frequent set of gamma/delta T cells are stimulated by protease-resistant ligands. Eur J Immunol (1990) 2.25

Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J Immunol (2001) 2.24

Bacterial DNA causes septic shock. Nature (1997) 2.19

Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med (2000) 2.16

Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes. Cell Immunol (1972) 2.15

Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol (1997) 2.10

Induction of cytotoxic T lymphocytes against I-region-coded determinants: in vitro evidence for a third histocompatibility locus in the mouse. J Exp Med (1975) 2.09

A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol (1991) 2.06

Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol (1994) 2.04

Perception and neuronal coding of subjective contours in the owl. Nat Neurosci (1999) 2.01

(+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.99

Cell-mediated immune response in vitro. 3. The requirement for macrophages in cytotoxic reactions against cell-bound and subcellular alloantigens. J Exp Med (1972) 1.89

The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. J Immunol (1977) 1.86

Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol (2003) 1.86

Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol (1998) 1.83

Operative lengthening of the femur. Clin Orthop Relat Res (1978) 1.81

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol (1997) 1.79

T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors. Immunol Rev (1980) 1.78

[Possibilities and experiences with cartilage transplantation]. Z Orthop Ihre Grenzgeb (1972) 1.78

Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am J Physiol (1999) 1.78

The Caregiver Quality of Life Index-Cancer (CQOLC) scale: development and validation of an instrument to measure quality of life of the family caregiver of patients with cancer. Qual Life Res (1999) 1.76

Neural encoding of binocular disparity: energy models, position shifts and phase shifts. Vision Res (1996) 1.74

T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity. Transplant Rev (1973) 1.74

IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol (2001) 1.73

Cell-mediated immune response in vitro. I. A new in vitro system for the generation of cell-mediated cytotoxic activity. Cell Immunol (1972) 1.67

Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun (1998) 1.64

Surface replacement arthroplasty of the hip. Clin Orthop Relat Res (1979) 1.63

T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells. Nature (1977) 1.61

Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo. J Exp Med (1981) 1.59

Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol (1985) (1996) 1.59

Detection of primary HIV infection by a second-generation HIV(p24) antigen test. Infusionsther Transfusionsmed (1994) 1.59

Antiinflammatory sydnones. 1. J Med Chem (1974) 1.59

Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins. Eur J Immunol (2000) 1.58

Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg (1999) 1.56

T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells. Eur J Immunol (1975) 1.56

Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol (1997) 1.56

Structural analysis of an RNA molecule involved in replication control of plasmid R1. Nucleic Acids Res (1986) 1.55

T-T cell interactions during in vitro cytotoxic T lymphocyte (CTL) responses. II. Helper factor from activated Lyt 1+ T cells is rate limiting i) in T cell responses to nonimmunogenic alloantigen, ii) in thymocyte responses to allogeneic stimulator cells, and III) recruits allo- or H-2-restricted CTL precursors from the Lyt 123+ T subset. J Immunol (1980) 1.55

Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur J Immunol (1993) 1.54

The correlation between the proliferative and the cytotoxic responses of mouse lymphocytes to allogeneic cells in vitro. J Immunol (1972) 1.54

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial. Lancet (2001) 1.53

Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood (2000) 1.51

Effect of prolonged, heavy exercise on pulmonary gas exchange in athletes. J Appl Physiol (1985) (1998) 1.51

Listeriosis in p47(phox-/-) and TRp55-/- mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity (1997) 1.50

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg (2000) 1.50

Interleukin 2 induction in Lyt 1+ 23- T cells from Listeria monocytogenes-immune mice. Infect Immun (1982) 1.49

[Total joint surfact replacement in the hip joint. Preliminary communication]. Arch Orthop Unfallchir (1975) 1.47

Aneurysm of the membranous ventricular septum. Surgical consideration and experience in 29 cases. J Thorac Cardiovasc Surg (1976) 1.46

Immunomodulation by intravenous immunoglobulin. Am J Pediatr Hematol Oncol (1990) 1.46

CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur J Immunol (1999) 1.46

Laser heat hyperalgesia is not a feature of non-specific chronic low back pain. Eur J Pain (2014) 1.45

Frequency of herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen- and antigen-driven primary in vitro T cell responses. J Immunol (1987) 1.44

[Stimulation interval-dependent acoustic evoked potentials]. Acta Otolaryngol (1974) 1.44

Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun (1997) 1.44

Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol (2002) 1.42

Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol (2001) 1.41

Complete DNA methylation does not prevent polyoma and simian virus 40 virus early gene expression. Proc Natl Acad Sci U S A (1983) 1.39

Integration of foreign sequences into the tobacco plastome via polyethylene glycol-mediated protoplast transformation. Planta (1996) 1.39

Plasmodium falciparum merozoites primarily stimulate the V gamma 9 subset of human gamma/delta T cells. Eur J Immunol (1991) 1.34

A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies. J Immunol Methods (1985) 1.33

Failure of an automated blood culture system to detect nonfermentative gram-negative bacteria. J Clin Microbiol (2000) 1.33

Superantigen and endotoxin synergize in the induction of lethal shock. Eur J Immunol (1997) 1.31

Impact of thymus on the generation of immunocompetence and diversity of antigen-specific MHC-restricted cytotoxic T-lymphocyte precursors. Immunol Rev (1981) 1.31

Superantigen mediated shock: a cytokine release syndrome. Immunobiology (1993) 1.29

Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance. J Clin Microbiol (1996) 1.29

In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo. Eur J Immunol (1973) 1.29

Function of the CD4 and CD8 molecules on human cytotoxic T lymphocytes: regulation of T cell triggering. J Immunol (1986) 1.27

Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine (1999) 1.27

Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J Immunol (2000) 1.26

Humoral and cell mediated responses in vitro of spleen cells from mice with thymic aplasia (nude mice). Aust J Exp Biol Med Sci (1972) 1.26

Exercise adaptation attenuates VEGF gene expression in human skeletal muscle. Am J Physiol Heart Circ Physiol (2000) 1.26

Critical review and meta-analysis of serial agitated dilutions in experimental toxicology. Hum Exp Toxicol (1994) 1.26

Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst (1989) 1.26

Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. J Immunol (1999) 1.25

Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif. J Immunol (1993) 1.24

DNA activates human immune cells through a CpG sequence-dependent manner. Immunology (1999) 1.23

Intrathymic differentiation of cytotoxic T lymphocyte (CTL) precursors. I. The CTL immunocompetence of peanut agglutinin-positive (cortical) and negative (medullary) Lyt 123 thymocytes. J Immunol (1980) 1.23